Hemoglobin solution to improve hemorrhagic shock treatment for combat medics
Active Purchase Order Awarded
- Contract number
- FA864926P0099
- Awardee
-
Reblood RX, Inc. UEI Y3YHZCHJ3285
- Awarding agency
-
Air Force Research Laboratory
Air Force Materiel Command, Department of Defense
- Obligated
- $74,881
Award facts
- Contract value 100% obligated
- $74,881.00 Current and potential, with all options
- Completion date 97% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92123, USA
Award details come from SAM.gov/FPDS.
About this award
The Air Force Research Laboratory awarded a purchase order to Reblood RX, Inc. for $74,881.00 on July 13, 2026, under a Total Small Business set-aside. The order procures a hemoglobin solution designed to improve hemorrhagic shock treatment for combat medics. Work is performed in San Diego, California. The order is due for ultimate completion on October 19, 2026.
Quick answers
Who was awarded contract FA864926P0099?
FA864926P0099 was awarded to Reblood RX, Inc. by Air Force Research Laboratory (Air Force Materiel Command) on July 13, 2026.
How much is contract FA864926P0099 worth?
The government has obligated $74,881 on FA864926P0099.
Was contract FA864926P0099 competed?
The extent of competition for FA864926P0099 was full and open competition after exclusion of sources. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award